Angiotensin converting enzyme 2 in patients with sepsis associate with comorbidities but neither with mortality nor with organ failure
(2025) In Scientific Reports 15(1).- Abstract
High levels of circulating angiotensin converting enzyme 2 (ACE2) are associated with several chronic diseases and mortality risk. Less is known about the prognostic value of ACE2 in patients with sepsis. In the present study, we aimed to investigate the association between plasma ACE2 levels on admission to the ED and 28-day mortality, organ failure, and level of care in a prospectively recruited observational study sample. Six hundred patients with sepsis admitted to the emergency in Malmö 2013–2015 were included in the analysis. Uni- and multivariable binary logistic regression was conducted to investigate the association between ACE2 and 28-day mortality, organ failure, and level of care. Plasma ACE2 levels were increased in... (More)
High levels of circulating angiotensin converting enzyme 2 (ACE2) are associated with several chronic diseases and mortality risk. Less is known about the prognostic value of ACE2 in patients with sepsis. In the present study, we aimed to investigate the association between plasma ACE2 levels on admission to the ED and 28-day mortality, organ failure, and level of care in a prospectively recruited observational study sample. Six hundred patients with sepsis admitted to the emergency in Malmö 2013–2015 were included in the analysis. Uni- and multivariable binary logistic regression was conducted to investigate the association between ACE2 and 28-day mortality, organ failure, and level of care. Plasma ACE2 levels were increased in patients with male sex, high age, and comorbidities, including diabetes, cardiovascular disease, and cancer. Plasma ACE2 levels associated with hospitalization and intermediate care unit stay in univariate but not multivariate analysis. Plasma ACE2 did neither associate with 28-day mortality, OR 1.19 (95% CI 0.86–1.65, p = 0.29), nor with organ failure, OR 1.08 (95% CI 0.73–1.56. p = 0.72). Future studies investigating the dynamics of circulating ACE2 levels in patients with sepsis longitudinally are warranted.
(Less)
- author
- Forsberg, Felix ; Ruge, Toralph LU ; Larsson, Anders ; Wändell, Per ; Carlsson, Axel C. ; Nilsson, Peter M. LU and Swärd, Per LU
- organization
- publishing date
- 2025-12
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Angiotensin converting enzyme 2 (ACE2), Comorbidities, Level of care, Mortality, Organ failure, Sepsis
- in
- Scientific Reports
- volume
- 15
- issue
- 1
- article number
- 14198
- publisher
- Nature Publishing Group
- external identifiers
-
- pmid:40268960
- scopus:105003577913
- ISSN
- 2045-2322
- DOI
- 10.1038/s41598-025-96640-0
- language
- English
- LU publication?
- yes
- id
- 0a11655e-b3e0-4b01-8af0-cd6f108bf42c
- date added to LUP
- 2025-07-14 09:53:04
- date last changed
- 2025-07-15 03:00:08
@article{0a11655e-b3e0-4b01-8af0-cd6f108bf42c,
abstract = {{<p>High levels of circulating angiotensin converting enzyme 2 (ACE2) are associated with several chronic diseases and mortality risk. Less is known about the prognostic value of ACE2 in patients with sepsis. In the present study, we aimed to investigate the association between plasma ACE2 levels on admission to the ED and 28-day mortality, organ failure, and level of care in a prospectively recruited observational study sample. Six hundred patients with sepsis admitted to the emergency in Malmö 2013–2015 were included in the analysis. Uni- and multivariable binary logistic regression was conducted to investigate the association between ACE2 and 28-day mortality, organ failure, and level of care. Plasma ACE2 levels were increased in patients with male sex, high age, and comorbidities, including diabetes, cardiovascular disease, and cancer. Plasma ACE2 levels associated with hospitalization and intermediate care unit stay in univariate but not multivariate analysis. Plasma ACE2 did neither associate with 28-day mortality, OR 1.19 (95% CI 0.86–1.65, p = 0.29), nor with organ failure, OR 1.08 (95% CI 0.73–1.56. p = 0.72). Future studies investigating the dynamics of circulating ACE2 levels in patients with sepsis longitudinally are warranted.</p>}},
author = {{Forsberg, Felix and Ruge, Toralph and Larsson, Anders and Wändell, Per and Carlsson, Axel C. and Nilsson, Peter M. and Swärd, Per}},
issn = {{2045-2322}},
keywords = {{Angiotensin converting enzyme 2 (ACE2); Comorbidities; Level of care; Mortality; Organ failure; Sepsis}},
language = {{eng}},
number = {{1}},
publisher = {{Nature Publishing Group}},
series = {{Scientific Reports}},
title = {{Angiotensin converting enzyme 2 in patients with sepsis associate with comorbidities but neither with mortality nor with organ failure}},
url = {{http://dx.doi.org/10.1038/s41598-025-96640-0}},
doi = {{10.1038/s41598-025-96640-0}},
volume = {{15}},
year = {{2025}},
}